A Scoping Review of the Quality and the Design of Evaluations of Mobile Health, Telehealth, Smart Pump and Monitoring Technologies Performed in a Pharmacy-Related Setting
Overview
Authors
Affiliations
There is currently a need for high quality evaluations of new mobile health, telehealth, smart pump and monitoring technologies undertaken in a pharmacy-related setting. We aim to evaluate the use of these monitoring technologies performed in this setting. A systematic searching of English articles that examined the quality and the design of technologies conducted in pharmacy-related facilities was performed using the following databases: MEDLINE and Cumulative index to Nursing and Allied Health Literature (CINAHL) to identify original studies examining the quality and the design of technologies and published in peer-reviewed journals. Extraction of articles and quality assessment of included articles were performed independently by two authors. Quality scores over 75% are classed as being acceptable using a "relatively conservative" quality benchmark. Scores over 55% are included using a "relatively liberal" cut-off point. Screening resulted in the selection of 40 formal evaluations. A substantial number of studies (32, 80.00%) were performed in the United States, quantitative in approach (33, 82.50%) and retrospective cohort (24, 60.00%) in study design. The most common pharmacy-related settings were: 22 primary care (55.00%); 10 hospital pharmacy (25.00%); 7 community pharmacy (17.50%); one primary care and hospital pharmacy (2.50%). The majority of the evaluations (33, 82.50%) reported clinical outcomes, six (15.00%) measured clinical and economic outcomes, and one (2.50%) economic only. Twelve (30.00%) quantitative studies and no qualitative study met objective criteria for "relatively conservative" quality. Using a lower "relatively liberal" benchmark, 27 quantitative (81.82%) and four qualitative (57.41%) studies met the lower quality criterion. Worldwide, few evaluations of mobile health, telehealth, smart pump and monitoring technologies in pharmacy-related setting have been published.Their quality is often below the standard necessary for inclusion in a systematic review mainly due to inadequate study design.
Nurlaela Arief N, Gustomo A, Rahman Roestan M, Putri A, Islamiaty M Heliyon. 2022; 8(8):e10347.
PMID: 36082329 PMC: 9445282. DOI: 10.1016/j.heliyon.2022.e10347.
Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes.
Al Ammari M, Althiab K, Aljohani M, Sultana K, Maklhafi N, AlOnazi H Front Pharmacol. 2021; 12:652482.
PMID: 34566632 PMC: 8459665. DOI: 10.3389/fphar.2021.652482.
A review of features and characteristics of smart medication adherence products.
Faisal S, Ivo J, Patel T Can Pharm J (Ott). 2021; 154(5):312-323.
PMID: 34484481 PMC: 8408912. DOI: 10.1177/17151635211034198.
Vassolo R, Mac Cawley A, Tortorella G, Fogliatto F, Tlapa D, Narayanamurthy G J Med Internet Res. 2021; 23(8):e27571.
PMID: 34435967 PMC: 8430851. DOI: 10.2196/27571.
Qualitative and Quantitative Analysis of Definitions of e-Health and m-Health.
Hallberg D, Salimi N Healthc Inform Res. 2020; 26(2):119-128.
PMID: 32547809 PMC: 7278507. DOI: 10.4258/hir.2020.26.2.119.